Correlation Between Enliven Therapeutics and Monopar Therapeutics
Can any of the company-specific risk be diversified away by investing in both Enliven Therapeutics and Monopar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enliven Therapeutics and Monopar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enliven Therapeutics and Monopar Therapeutics, you can compare the effects of market volatilities on Enliven Therapeutics and Monopar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enliven Therapeutics with a short position of Monopar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enliven Therapeutics and Monopar Therapeutics.
Diversification Opportunities for Enliven Therapeutics and Monopar Therapeutics
0.4 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Enliven and Monopar is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and Monopar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monopar Therapeutics and Enliven Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enliven Therapeutics are associated (or correlated) with Monopar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monopar Therapeutics has no effect on the direction of Enliven Therapeutics i.e., Enliven Therapeutics and Monopar Therapeutics go up and down completely randomly.
Pair Corralation between Enliven Therapeutics and Monopar Therapeutics
Given the investment horizon of 90 days Enliven Therapeutics is expected to generate 8.23 times less return on investment than Monopar Therapeutics. But when comparing it to its historical volatility, Enliven Therapeutics is 6.24 times less risky than Monopar Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Monopar Therapeutics is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 1,350 in Monopar Therapeutics on September 3, 2024 and sell it today you would earn a total of 903.00 from holding Monopar Therapeutics or generate 66.89% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enliven Therapeutics vs. Monopar Therapeutics
Performance |
| Timeline |
| Enliven Therapeutics |
| Monopar Therapeutics |
Enliven Therapeutics and Monopar Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enliven Therapeutics and Monopar Therapeutics
The main advantage of trading using opposite Enliven Therapeutics and Monopar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enliven Therapeutics position performs unexpectedly, Monopar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monopar Therapeutics will offset losses from the drop in Monopar Therapeutics' long position.| Enliven Therapeutics vs. DiaMedica Therapeutics | Enliven Therapeutics vs. Lyra Therapeutics | Enliven Therapeutics vs. Centessa Pharmaceuticals PLC |
| Monopar Therapeutics vs. Anebulo Pharmaceuticals | Monopar Therapeutics vs. Acrivon Therapeutics, Common | Monopar Therapeutics vs. Pmv Pharmaceuticals | Monopar Therapeutics vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |